Pazenir

Medicinal product

(Invented) name

Pazenir

Active substance (s)

Paklitakselis

Strength

5 mg/ml

Pharmaceutical form

milteliai dispersinei infuzijai

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CD01, Paclitaxel

Marketing authorisation holder

ratiopharm GmbH, Vokietija

Date of authorisation

2019-05-06

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for dispersion for infusion	1 ml
Paklitakselis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101609	87713	1087713	flakonas	20 ml N1		Receptinis	EU/1/18/1317/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-05-06	Registruotas